Implante intravítreo de dexametasona como terapéutica del edema macular persistente en la retinocoroidopatía de Birdshot
- P. Rivera de Zea
- A. García-Ben
- N. Rachwani Parshotam
- J.M. García-Campos
ISSN: 0365-6691
Year of publication: 2016
Volume: 91
Issue: 3
Pages: 138-141
Type: Article
More publications in: Archivos de la Sociedad Española de Oftalmologia
Abstract
Clinical case The case is reported of a 32 year-old man with a bilateral cystoid macular oedema and serous macular detachment due to birdshot retinochoroidopathy. An intravitreal implant of 0.7 mg dexamethasone (Ozurdex®, Allergan) was performed on both eyes, after a partial response of the macular oedema to oral and subtenon corticosteroids. Anatomical and visual improvements were observed and maintained after six months of follow up. Discussion Intravitreal dexamethasone implant may be a good therapeutic option in patients with macular oedema due to Birdshot retinochoroidopathy, and who were refractory or had intolerance to previous therapies.